Interaction of CD99 with its paralog CD99L2 positively regulates CD99L2 trafficking to cell surfaces

Journal of Immunology

Volumn 191, Issue 11, 2013, Pages 5730-5742

  Nam, Giri ^a   Lee, Young Kwan ^a   Lee, Hye Yeong ^a   Ma, Min Jung ^a   Araki, Masatake ^b   Araki, Kimi ^b   Lee, Seungbok ^a   Lee, Im Soon ^c   Choi, Eun Young ^a  

^a Seoul National University   (South Korea)

^b KUMAMOTO UNIVERSITY   (Japan)

^c Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD99 ANTIGEN; CD99 LIKE 2 ANTIGEN; HETERODIMER; HOMODIMER; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIMERIZATION; EMBRYO; HUMAN; HUMAN CELL; LEUKOCYTE; MEMBRANE TRANSPORT; MOUSE; MUTANT; NONHUMAN; PARALOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; THYMOCYTE; WILD TYPE;

EID: 84888359333     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203062     Document Type: Article

References (44)

1. Bixel, G., S. Kloep, S. Butz, B. Petri, B. Engelhardt, and D. Vestweber. 2004. Mouse CD99 participates in T-cell recruitment into inflamed skin. Blood 104: 3205-3213.
2. + thymocytes. J. Immunol. 154: 26-32.
3. 1-dependent T cell adhesion to inflamed vascular endothelium under flow conditions. Eur. J. Immunol. 30: 3061-3065.
4. Schenkel, A. R., Z. Mamdouh, X. Chen, R. M. Liebman, and W. A. Muller. 2002. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat. Immunol. 3: 143-150.
5. Lou, O., P. Alcaide, F. W. Luscinskas, and W. A. Muller. 2007. CD99 is a key mediator of the transendothelial migration of neutrophils. J. Immunol. 178: 1136-1143.
6. Dufour, E. M., A. Deroche, Y. Bae, and W. A. Muller. 2008. CD99 is essential for leukocyte diapedesis in vivo. Cell Commun. Adhes. 15: 351-363.
7. Suh, Y. H., Y. K. Shin, M. C. Kook, K. I. Oh, W. S. Park, S. H. Kim, I. S. Lee, H. J. Park, T. L. Huh, and S. H. Park. 2003. Cloning, genomic organization, alternative transcripts and expression analysis of CD99L2, a novel paralog of human CD99, and identification of evolutionary conserved motifs. Gene 307: 63-76.
8. Bixel, M. G., B. Petri, A. G. Khandoga, A. Khandoga, K. Wolburg-Buchholz, H. Wolburg, S. März, F. Krombach, and D. Vestweber. 2007. A CD99-related antigen on endothelial cells mediates neutrophil but not lymphocyte extravasation in vivo. Blood 109: 5327-5336.
9. Schenkel, A. R., E. M. Dufour, T. W. Chew, E. Sorg, and W. A. Muller. 2007. The murine CD99-related molecule CD99-like 2 (CD99L2) is an adhesion molecule involved in the inflammatory response. Cell Commun. Adhes. 14: 227-237.
10. Bixel, M. G., H. Li, B. Petri, A. G. Khandoga, A. Khandoga, A. Zarbock, K. Wolburg-Buchholz, H. Wolburg, L. Sorokin, D. Zeuschner, et al. 2010. CD99 and CD99L2 act at the same site as, but independently of, PECAM-1 during leukocyte diapedesis. Blood 116: 1172-1184.
11. Kim, S. H., Y. K. Shin, I. S. Lee, Y. M. Bae, H. W. Sohn, Y. H. Suh, H. J. Ree, M. Rowe, and S. H. Park. 2000. Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype. Blood 95: 294-300.
12. Sohn, H. W., Y. K. Shin, I. S. Lee, Y. M. Bae, Y. H. Suh, M. K. Kim, T. J. Kim, K. C. Jung, W. S. Park, C. S. Park, et al. 2001. CD99 regulates the transport of MHC class I molecules from the Golgi complex to the cell surface. J. Immunol. 166: 787-794.
13. Gil, M. C., M. H. Lee, J. I. Seo, Y. L. Choi, M. K. Kim, K. C. Jung, S. H. Park, and T. J. Kim. 2002. Characterization and epitope mapping of two monoclonal antibodies against human CD99. Exp. Mol. Med. 34: 411-418.
14. Brémond, A., O. Meynet, K. Mahiddine, S. Coito, M. Tichet, K. Scotlandi, J. P. Breittmayer, P. Gounon, P. A. Gleeson, A. Bernard, and G. Bernard. 2009. Regulation of HLA class I surface expression requires CD99 and p230/golgin- 245 interaction. Blood 113: 347-357.
15. Pata, S., P. Otáhal, T. Brdička, W. Laopajon, K. Mahasongkram, and W. Kasinrerk. 2011. Association of CD99 short and long forms with MHC class I, MHC class II and tetraspanin CD81 and recruitment into immunological synapses. BMC Res. Notes 4: 293.
16. Mamdouh, Z., A. Mikhailov, and W. A. Muller. 2009. Transcellular migration of leukocytes is mediated by the endothelial lateral border recycling compartment. J. Exp. Med. 206: 2795-2808.
17. Choi, G., S. W. Lee, K. C. Jung, and E. Y. Choi. 2007. Detection of homodimer formation of CD99 through extracelluar domain using bimolecular fluorescence complementation analysis. Exp. Mol. Med. 39: 746-755.
18. Lee, M. K., H. S. Kim, S. S. Kim, M. H. Cho, and I. S. Lee. 2008. Analysis of the dimerization of human CD99 using bimolecular fluorescence complementation technique. J. Microbiol. Biotechnol. 18: 472-476.
19. Araki, K., M. Araki, and K. Yamamura. 1997. Targeted integration of DNA using mutant lox sites in embryonic stem cells. Nucleic Acids Res. 25: 868-872.
20. Choi, E. Y., Y. Yoshimura, G. J. Christianson, T. J. Sproule, S. Malarkannan, N. Shastri, S. Joyce, and D. C. Roopenian. 2001. Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others. J. Immunol. 166: 4370-4379.
21. Kerppola, T. K. 2006. Visualization of molecular interactions by fluorescence complementation. Nat. Rev. Mol. Cell Biol. 7: 449-456.
22. Wong, K. A., and J. P. O'Bryan. 2011. Bimolecular fluorescence complementation. J. Vis. Exp. (50).
23. Masi, A., R. Cicchi, A. Carloni, F. S. Pavone, and A. Arcangeli. 2010. Optical methods in the study of protein-protein interactions. Adv. Exp. Med. Biol. 674: 33-42.
24. Liu, J., S. A. Ernst, S. E. Gladycheva, Y. Y. Lee, S. I. Lentz, C. S. Ho, Q. Li, and E. L. Stuenkel. 2004. Fluorescence resonance energy transfer reports properties of syntaxin1a interaction with Munc18-1 in vivo. J. Biol. Chem. 279: 55924-55936.
25. Karpova, T., and J. G. McNally. 2006. Detecting protein-protein interactions with CFP-YFP FRET by acceptor photobleaching. Curr Protoc. Cytom. Chapter 12: Unit 12.17.
26. Shyu, Y. J., and C. D. Hu. 2008. Fluorescence complementation: an emerging tool for biological research. Trends Biotechnol. 26: 622-630.
27. Várnai, P., and T. Balla. 1998. Visualization of phosphoinositides that bind pleckstrin homology domains: calcium- and agonist-induced dynamic changes and relationship to myo-[3H]inositol-labeled phosphoinositide pools. J. Cell Biol. 143: 501-510.
28. Teruel, M. N., T. A. Blanpied, K. Shen, G. J. Augustine, and T. Meyer. 1999. A versatile microporation technique for the transfection of cultured CNS neurons. J. Neurosci. Methods 93: 37-48.
29. Zinchuk, V., and O. Grossenbacher-Zinchuk. 2009. Recent advances in quantitative colocalization analysis: focus on neuroscience. Prog. Histochem. Cytochem. 44: 125-172.
30. Kim, S. H., E. Y. Choi, Y. K. Shin, T. J. Kim, D. H. Chung, S. I. Chang, N. K. Kim, and S. H. Park. 1998. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mic2). Blood 92: 4287- 4295.
31. Barrett, S. P., P. A. Gleeson, H. de Silva, B. H. Toh, and I. R. van Driel. 1996. Interferon-g is required during the initiation of an organ-specific autoimmune disease. Eur. J. Immunol. 26: 1652-1655.
32. Kakinuma, T., H. Ichikawa, Y. Tsukada, T. Nakamura, and B. H. Toh. 2004. Interaction between p230 and MACF1 is associated with transport of a glycosyl phosphatidyl inositol-anchored protein from the Golgi to the cell periphery. Exp. Cell Res. 298: 388-398.
33. Barth, H., R. Cerino, M. Arcuri, M. Hoffmann, P. Schürmann, M. I. Adah, B. Gissler, X. Zhao, V. Ghisetti, B. Lavezzo, et al. 2005. Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes. J. Virol. 79: 5774-5785.
34. Richardson, R. M., R. J. Marjoram, L. S. Barak, and R. Snyderman. 2003. Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.
35. Trettel, F., S. Di Bartolomeo, C. Lauro, M. Catalano, M. T. Ciotti, and C. Limatola. 2003. Ligand-independent CXCR2 dimerization. J. Biol. Chem. 278: 40980-40988.
36. Martínez Muñoz, L., P. Lucas, G. Navarro, A. I. Checa, R. Franco, C. Martínez-A, J. M. Rodríguez-Frade, and M. Mellado. 2009. Dynamic regulation of CXCR1 and CXCR2 homo- and heterodimers. J. Immunol. 183: 7337-7346.
37. Achour, L., M. G. Scott, H. Shirvani, A. Thuret, G. Bismuth, C. Labbé-Jullié, and S. Marullo. 2009. CD4-CCR5 interaction in intracellular compartments contributes to receptor expression at the cell surface. Blood 113: 1938-1947.
38. Charette, N., P. Holland, J. Frazer, H. Allen, and D. J. Dupré. 2011. Dependence on different Rab GTPases for the trafficking of CXCR4 and CCR5 homo or heterodimers between the endoplasmic reticulum and plasma membrane in Jurkat cells. Cell. Signal. 23: 1738-1749.
39. Shiratori, I., K. Ogasawara, T. Saito, L. L. Lanier, and H. Arase. 2004. Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor. J. Exp. Med. 199: 525-533.
40. Park, H. J., Y. L. Ban, D. Byun, S. H. Park, and K. C. Jung. 2010. Interaction between the mouse homologue of CD99 and its ligand PILR as a mechanism of T cell receptor-independent thymocyte apoptosis. Exp. Mol. Med. 42: 353-365.
41. Bernard, G., J. P. Breittmayer, M. de Matteis, P. Trampont, P. Hofman, A. Senik, and A. Bernard. 1997. Apoptosis of immature thymocytes mediated by E2/ CD99. J. Immunol. 158: 2543-2550.
42. Sohn, H. W., E. Y. Choi, S. H. Kim, I. S. Lee, D. H. Chung, U. A. Sung, D. H. Hwang, S. S. Cho, B. H. Jun, J. J. Jang, et al. 1998. Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells. Am. J. Pathol. 153: 1937-1945.
43. Scotlandi, K., N. Baldini, V. Cerisano, M. C. Manara, S. Benini, M. Serra, P. L. Lollini, P. Nanni, G. Nicoletti, G. Bernard, et al. 2000. CD99 engagement: an effective therapeutic strategy for Ewing tumors. Cancer Res. 60: 5134-5142.
44. Husak, Z., D. Printz, A. Schumich, U. Potschger, and M. N. Dworzak. 2010. Death induction by CD99 ligation in TEL/AML1-positive acute lymphoblastic leukemia and normal B cell precursors. J. Leukoc. Biol. 88: 405-412.